Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04117152 · ClinicalTrials.gov registry record
Trajectories of Cardiac Allograft Vasculopathy After Heart Transplantation
A clinical trial of Heart Transplantation and Allograft Arteriopathy, sponsored by Paris Translational Research Center for Organ Transplantation.
- Completed
- Registry status
- 1,300
- Enrollment target
- 3
- Study locations
NCT04117152: Completed study of Heart Transplantation and Allograft Arteriopathy, sponsored by Paris Translational Research Center for Organ Transplantation.
NCT04117152 is a study of Heart Transplantation and Allograft Arteriopathy that has completed, run by Paris Translational Research Center for Organ Transplantation. The registered enrollment target is 1,300 participants, above the 267-participant average among 4 other Heart Transplantation trials with a reported enrollment target (387% higher). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04117152, a study of Heart Transplantation and Allograft Arteriopathy, has completed, sponsored by Paris Translational Research Center for Organ Transplantation.
- COMPLETED
- Registry status
- 1,300 participants
- Enrollment target
- 3
- Study locations
Study Summary
This project aims: i) to identify Cardiac Allograft Vasculopathy (CAV) trajectories after heat transplantation using latent class mixed modeling, ii) to characterize the global and specific determinants of different trajectories and iii) to provide an easily accessible tool to project individual probability of CAV trajectory belonging.
Primary Outcome
Identification of different evolutive profiles of CAV using latent classes mixed models. Each coronary angiogram was graded from 0 (no CAV) to 3 (severe CAV) according to ISHLT classification.
Conditions Studied
Interventions
- OTHER Latent class mixed modeling
Study Locations (3)
Other
- Maarten Naesens - Leuven
- Paris Transplant Group - Paris
California
- Jon Kobashigawa - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,300 participants |
| Start Date | 2004-01-01 |
| Est. Completion | 2020-06 |
What the finished NCT04117152 record still lists
NCT04117152 is an observational study that tracks outcomes without assigning an intervention. Its 1,300 participants enrollment target places it among the larger protocols in the corpus, above the 267-participant average among 4 other Heart Transplantation trials with a reported enrollment target (387% higher).
The record links to 2 conditions, with Heart Transplantation appearing as the primary indexed condition, and to 1 intervention - of which Latent class mixed modeling is the first listed.
NCT04117152 reports a single indexed study location in Other, California.
Frequently Asked Questions
What is clinical trial NCT04117152 about?
NCT04117152 is a clinical study titled "Trajectories of Cardiac Allograft Vasculopathy After Heart Transplantation". This project aims: i) to identify Cardiac Allograft Vasculopathy (CAV) trajectories after heat transplantation using latent class mixed modeling, ii) to characterize the global and specific determinants of different trajectories and iii) to provide an easily accessible tool to project individual pro...
What is the current status of trial NCT04117152?
This trial is currently completed. The enrollment target is 1,300 participants. The study started on 2004-01-01. Estimated completion is 2020-06.
What conditions does trial NCT04117152 study?
This clinical trial studies the following conditions: Heart Transplantation, Allograft Arteriopathy.
What interventions are being tested in trial NCT04117152?
The interventions under investigation include: Latent class mixed modeling (OTHER).
Who is sponsoring clinical trial NCT04117152?
This trial is sponsored by Paris Translational Research Center for Organ Transplantation, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04117152 being conducted?
This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Transplantation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Belatacept in De Novo Heart Transplantation
RECRUITING · Phase 2
-
Magnetocardiography as a Non-Invasive Tool for Detecting Tissue Rejection in Heart Transplant Patients
COMPLETED · Phase 3
-
A Study of Safety, Tolerability & Efficacy of Certican in de Novo Heart Transplant (Tx) Patients
COMPLETED · Phase 3
-
Study to Ascertain if Prolonged Release Tacrolimus (FK506E - MR4) is Safe and Effective When Used in the Long Term and in Combination With Other Immunosuppressive Drugs in Patients Who Have Received a Transplant
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04474223 · 1,300 participants · Phase 3
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
- NCT04792684 · 1,300 participants
Collection of Samples USOPTIVAL Study
- NCT05166694 · 1,300 participants · NA
Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions
- NCT05282654 · 1,300 participants · NA
Real-time Symptom Monitoring Using ePROs to Prevent Adverse Events During Care Transitions
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI